BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7936243)

  • 1. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992.
    Bacellar H; Muñoz A; Miller EN; Cohen BA; Besley D; Selnes OA; Becker JT; McArthur JC
    Neurology; 1994 Oct; 44(10):1892-900. PubMed ID: 7936243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
    Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
    Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuro-cognitive disorders on the rise.
    Link D
    GMHC Treat Issues; 1995 Mar; 9(3):7-8. PubMed ID: 11362361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
    Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
    Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998.
    Sacktor N; Lyles RH; Skolasky R; Kleeberger C; Selnes OA; Miller EN; Becker JT; Cohen B; McArthur JC;
    Neurology; 2001 Jan; 56(2):257-60. PubMed ID: 11160967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS).
    Kingsley LA; Zhou SY; Bacellar H; Rinaldo CR; Chmiel J; Detels R; Saah A; VanRaden M; Ho M; Muñoz A
    Am J Epidemiol; 1991 Aug; 134(4):331-9. PubMed ID: 1877593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Multicenter AIDS Cohort Study: Rationale, Organization, and Selected Characteristics of the Particpants.
    Am J Epidemiol; 2017 Jun; 185(11):1148-1156. PubMed ID: 30052739
    [No Abstract]   [Full Text] [Related]  

  • 8. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy.
    Baldeweg T; Catalan J; Gazzard BG
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):34-41. PubMed ID: 9667558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].
    Klatt EC; Nichols L; Noguchi TT
    Arch Pathol Lab Med; 1994 Sep; 118(9):884-90. PubMed ID: 8080357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic conditions are difficult to treat.
    van Baelen G
    GMHC Treat Issues; 1995 Mar; 9(3):8-11. PubMed ID: 11362362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurologic manifestations of AIDS.
    McArthur JC
    Medicine (Baltimore); 1987 Nov; 66(6):407-37. PubMed ID: 3316921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV/AIDS patients.
    Dragovic G; Jevtovic D
    Antivir Chem Chemother; 2003 Sep; 14(5):281-4. PubMed ID: 14694991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptococcal meningitis.
    Wang F; So Y; Vittinghoff E; Malani H; Reingold A; Lewis E; Giordano J; Janssen R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):75-82. PubMed ID: 8548350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide survey of neurologic manifestations of acquired immunodeficiency syndrome in Japan.
    Nakagawa M; Maruyama Y; Sugita H; Osame M
    Intern Med; 1997 Mar; 36(3):175-8. PubMed ID: 9144008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological complications in AIDS patients: the 1-year retrospective study in Chiang Mai University, Thailand.
    Subsai K; Kanoksri S; Siwaporn C; Helen L
    Eur J Neurol; 2004 Nov; 11(11):755-9. PubMed ID: 15525297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurological complications with HIV infection].
    Miura Y; Kishida S
    Brain Nerve; 2013 Mar; 65(3):275-81. PubMed ID: 23475519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.
    Childs EA; Lyles RH; Selnes OA; Chen B; Miller EN; Cohen BA; Becker JT; Mellors J; McArthur JC
    Neurology; 1999 Feb; 52(3):607-13. PubMed ID: 10025796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the 1978-1990 and future spread of human immunodeficiency virus type 1 in subgroups of homosexual men.
    Hoover DR; Muñoz A; Carey V; Chmiel JS; Taylor JM; Margolick JB; Kingsley L; Vermund SH
    Am J Epidemiol; 1991 Nov; 134(10):1190-205. PubMed ID: 1746529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.